Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer

Clinical trial NCT02974933 · UNKNOWN

Trial details

NCT number: NCT02974933
Sponsor: Wuling Ou
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nonsmall Cell Lung Cancer

Start date: 2016-11-01
Primary completion: 2017-11-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.